Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPI

Journal of Autoimmunity

Volumn 27, Issue 4, 2006, Pages 266-271

  Iverson, G Michael ^a   von Mühlen, Carlos A ^b   Staub, Henrique L ^b   Lassen, Andrew J ^a   Binder, Walter ^a   Norman, Gary L ^a  

^a INOVA DIAGNOSTICS INC   (United States)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

2 GPI; Atherosclerosis

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MUTANT PROTEIN; RECOMBINANT BETA2 GLYCOPROTEIN 1; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SERUM;

ANTIBODIES, ANTICARDIOLIPIN; ATHEROSCLEROSIS; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOGLOBULIN A; PROTEIN STRUCTURE, TERTIARY;

EID: 33846685872     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.09.007     Document Type: Article

References (17)

1. Ranzolin A., Bohn J.M., Norman G.L., Manenti E., Bodanese L.C., von Muhlen C.A., et al. Anti-beta2-glycoprotein I antibodies as risk factors for acute myocardial infarction. Arg Bras Cardiol 83 2 (2004 Aug) 141-144 137-40
2. Kahles T., Humpich M., Steinmetz H., Sitzer M., and Lindhoff-Last E. Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke. Rheumatology (Oxford) 44 9 (2005) 1161-1165
3. Staub H.L., Norman G.L., Crowther T., da Cunha V.R., Polanczyk A., Bohn J.M., et al. Antibodies to the atherosclerotic plaque components beta2-glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemia. Arq Neuropsiquiatr 61 3B (2003) 757-763
4. Lozier J., Takahashi N., and Putnam F.W. Complete amino acid sequence of human plasma beta 2-glycoprotein I. Proc Natl Acad Sci U S A 81 (1984) 3640-3644
5. Hunt J., Simpson R.J., and Krillis S.A. Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc Natl Acad Sci U S A 90 (1993) 2141-2145
6. Blank M., Shoenfeld Y., Cabilly S., Heldman Y., Fridkin M., and Katchalski-Katsier E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A 96 (1999) 5164-5168
7. Koike T., Ichikawa K., Atsumi H., Kasahara T., and Matsuura E. B2-glycoprotein I anti-B2-glycoprotein I interactions. J Autoimmun 15 (2000) 97-100
8. Yang C.D., Chen S.L., Shen N., Pei J., Xue F., Lu Y., et al. The fifth domain of B2-glycoprotein I contains antigenic epitopes recognized by anticardiolipin antibodies derived from patients with the antiphospholipid syndrome. APLAR J Rheumatol 1 (1997) 96-100
9. Iverson G.M., Victoria E.J., and Marquis D.M. Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci U S A 95 (1998) 15542-15546
10. McNeely P.A., Dlott J.S., Frie R.A., Jack R.M., Ortel T.L., Triplett D.A., et al. B2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of B2-glycoprotein I. Thromb Haemost 86 (2001) 590-595
11. Iverson G.M., Matsuura E., Victoria E.J., Cockerill K.A., and Linnik M.D. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA. J Autoimmun 18 (2002) 289-297
12. Igarashi M., Matsuura E., Igarashi Y., Nagae H., Ichikawa K., Triplett D.A., et al. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. Blood 87 8 (1996) 3262-3270
13. Iverson G.M., Reddel S., Victoria E.J., Cockerill K.A., Wang Y.-X., Marti-Renom M.A., et al. Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol 169 (2002) 7097-7103
14. George J., Gilburd B., Hojnik M., Levy Y., Langevitz P., Matsuura E., et al. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding. J Immunol 160 8 (1998) 3917-3923
15. Kasahara H., Matsuura E., Kaihara K., Yamamoto D., Kobayashi K., Inagaki J., et al. Antigenic structures recognized by anti-beta2-glycoprotein l autoantibodies. Int Immunol 17 (2005) 1533-1542
16. Iverson G.M., Victoria E.J., Cockerill K.A., and Linik M.D. Advances in understanding what we measure when detecting anticardiolipin autoantibodies. Clin Chim Acta 343 (2004) 37-44
17. Staub HL, Frank M, Ranzolin A, Norman GL, Iverson GM, von Muhlen CA. IgA antibodies to beta2-glycoprotein I and atherosclerosis. Autoimmun Rev, in press.